APHA

517% GAIN ON THIS ARORA MARIJUANA PORTFOLIO COMPANY

By Nigam Arora & Dr. Natasha Arora 517% Gain Congratulations! Arena Pharmaceuticals (ARNA), a biotech associated with marijuana, has received a $100 per share all-cash offer from Pfizer (PFE).  ARNA is long from the original Arora buy signal from $16.20.  At a $100 cash offer, it represents a gain of 517%. Arena has

Read More

LAST DAY: LOOK AT THESE GAINS — UP TO 681% IN ABOUT ONE MONTH

Deadline You make good financial decisions.  Today is the last day to take advantage of the double special offer.  The time to act is now. Astounding Gains The profits in Marijuana Model Portfolio have been astounding.  There are 11 stocks in the portfolio.  Look at these gains that were available

Read More

DEADLINE IS HERE: LOOK AT THESE GAINS — UP TO 681% IN ABOUT ONE MONTH

Deadline You make good financial decisions.  The deadline to take advantage of the double special offer is only three days away.  The time to act is now. Astounding Gains The profits in Marijuana Model Portfolio have been astounding.  There are 11 stocks in the portfolio.  Look at these gains that

Read More

A DOUBLE SPECIAL OFFER: LOOK AT THESE GAINS — UP TO 681% IN ABOUT ONE MONTH

Astounding Gains The profits in Marijuana Model Portfolio have been astounding.  There are 11 stocks in the portfolio.  Look at these gains that were available in about a month based on the Arora signals given. ARNA 6% CGC 95% CRLBF 62% CRON 118% CURLF 35% GRWG 57% GTBIF 52% GWPH

Read More

SALE: A DOUBLE SPECIAL OFFER: LOOK AT THESE GAINS — UP TO 681% IN ABOUT ONE MONTH

Astounding Gains The profits in Marijuana Model Portfolio have been astounding.  There are 11 stocks in the portfolio.  Look at these gains in about a month as of this writing.  There is likely to be a sharp pullback and that is why our call has been to take profits. ARNA 6%

Read More

129% GAIN ON MARIJUANA STOCK TILRY IN NINE TRADING DAYS

On January 5th, right before the Georgia election, we gave a signal to buy marijuana stocks.  We provided 12 marijuana stocks as part of the Core Marijuana Model Portfolio. Aphria (APHA) has been in the Core Marijuana Model Portfolio for a long time.   APHA is now merging with Tilray (TLRY). The

Read More

BIGGEST MARIJUANA COMPANY FORMED BY MERGER — MORE OPPORTUNITIES AHEAD

  Aphria (APHA) is a Marijuana Model Portfolio stock. APHA is merging with Tilray (TLRY).  The merger will create the largest marijuana company — bigger than Canopy Growth (CGC).  CGC, in addition to being in the Marijuana Model Portfolio, is also in the Core Model Portfolio. This is an all stock deal.  APHA shareholders will

Read More

WEEKLY MARKET DIGEST: SLOWEST GROWTH IN CHINA IN 29 YEARS, DECEMBER DATA BULLISH, NEW STOCK MARKET HIGH $DIA $GLD $QQQ $SLV $SPY $TBT $USO

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market

Read More

WEEKLY MARKET DIGEST: SMART MONEY SELLS THE RALLY ON CHINA TRADE DEAL, CONSERVATIVES BEAT LIBERALS IN U. K. $DIA $GLD $QQQ $SLV $SPY $TBT $USO

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market

Read More

MARIJUANA: HERE’S HOW INVESTORS SHOULD THINK ABOUT THE FDA’S WARNING ON CBD $APHA $CGC $CRON $NBEV $ACB $MJ $TLRY $GTBIF $KSHB $GWPH $SMG

The U.S. Food and Drug Administration has thrown a big impediment in the way of marijuana investors. Before discussing the FDA’s move, let’s build some background with the help of a chart. Please click here for a chart showing segmented money flows in 16 popular marijuana stocks. Note the following: • Smart

Read More

Do you want to gain an edge in the markets? Join thousands of your fellow investors and money managers to subscribe to Generate Wealth newsletter.

FREE FOREVER

Follow The Most Accurate Stock Market Analysis

Unrivaled Insights
In Bull and Bear Markets

Generate Wealth Newsletter
Free Forever

Generate Wealth Newsletter
Free Forever